Artesunate/sulfadoxine/pyrimethamine is an artesunate-based oral medication used to treat malaria.[1] It consists of artesunate and sulfadoxine/pyrimethamine.[2]
Combination of | |
---|---|
Artesunate | Antimalarial |
Sulfadoxine | Sulfonamide antimalarial |
Pyrimethamine | Antimalarial |
References
edit- ^ Arya A, Kojom Foko LP, Chaudhry S, Sharma A, Singh V (April 2021). "Artemisinin-based combination therapy (ACT) and drug resistance molecular markers: A systematic review of clinical studies from two malaria endemic regions - India and sub-Saharan Africa". International Journal for Parasitology: Drugs and Drug Resistance. 15: 43–56. doi:10.1016/j.ijpddr.2020.11.006. PMC 7887327. PMID 33556786.
- ^ "Artesunate+Sulfadoxine-Pyrimethamine for the Treatment of Uncomplicated Falciparum Malaria (ASPF)". clinicaltrials.gov. University of Oxford. July 11, 2012. Retrieved June 6, 2017.